Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality

被引:3
|
作者
Na, Hee Young [1 ]
Kim, Jee Hyun [2 ]
Kim, Haeryoung [3 ]
Cho, Jai Young [4 ]
Han, Ho-Seong [4 ]
Jang, Eun Sun [5 ]
Kim, Jin-Wook [5 ]
Jeong, Sook-Hyang [5 ]
Heo, Jayoon [2 ,6 ]
Kim, Ji-Won [2 ]
Kim, Jin Won [2 ]
Ahn, Soomin [1 ,7 ,8 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Coll Med, Seongnam, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Hematol & Med Oncol,Bundang Hosp, Seongnam, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul Natl Univ Hosp, Seoul, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Surg, Seongnam, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Bundang Hosp, Seongnam, South Korea
[6] Ilsan Hosp, Dept Internal Med, Natl Hlth Insurance Serv, Goyang, South Korea
[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[8] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol & Translat Genom, Sch Med, 81 Irwon ro, Seoul 06351, South Korea
关键词
combined hepatocellular-cholangiocarcinoma; intermediate cell carcinoma; liver; next-generation sequencing; CARCINOMA;
D O I
10.1111/his.15081
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of liver tumour that exhibits both hepatocytic and biliary differentiation within the same tumour. The histology and genomic alterations of recurrent/metastatic cHCC-CC are poorly understood. We selected six patients with cHCC-CC whose recurrent or metastatic tumours were histologically confirmed. Four patients with classic cHCC-CCs and two with intermediate cell carcinomas (ICs) were included. The clinicopathological features were evaluated, and next-generation sequencing was performed in 17 multiregional and longitudinal tumour samples. The histology of recurrent/metastatic lesions of classic cHCC-CCs was variable: hepatocellular carcinoma (HCC) was observed in one (25.0%) patient, cHCC-CC in one (25.0%) patient, and cholangiocarcinoma (CC) in two (50.0%) patients. Among 13 samples from four classic cHCC-CC patients, the most frequent pathological variants were TP53 (46.2%), TERT promoter (38.5%), ARID1A mutations (23.1%), and MET amplification (30.8%). In the sequencing analysis of each HCC and CC component, three (75.0%) of the four classic cHCC-CCs shared pathogenic variants. A large proportion of mutations, both pathogenic and those of undetermined significance, were shared by each HCC and CC component. Regarding ICs, the ATM mutation was detected in one patient. In conclusion, the histology of recurrent/metastatic cHCC-CCs was heterogeneous. Genomic profiling of classic cHCC-CCs revealed similar genomic alterations to those of HCC. Considerable overlapping genomic alterations in each HCC and CC component were observed, suggesting a monoclonal origin. Genetic alterations in ICs were different from those in either HCC or CC, suggesting the distinct nature of this tumour. The histology of recurrent/metastatic tumours of cHCC-CCs was variable. Genomic profiling of cHCC-CC revealed considerable overlapping genomic alterations in each HCC and CC component.image
引用
收藏
页码:402 / 408
页数:7
相关论文
共 50 条
  • [41] Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends
    Jiakun Wang
    Enliang Li
    Hao Yang
    Junjun Wu
    Hong cheng Lu
    Chenhao Yi
    Jun Lei
    Wenjun Liao
    Linquan Wu
    World Journal of Surgical Oncology, 17
  • [42] MOLECULAR CLASSIFICATION OF MIXED HEPATOCELLULAR-CHOLANGIOCARCINOMA TUMORS
    Moeini, A.
    Sia, D.
    Zhang, Z.
    Camprecios, G.
    Stueck, A.
    Fiel, M. Isabel
    Miltiadous, O.
    Quetglas, I. M.
    Hao, Ke
    Villanueva, A.
    Thung, S. N.
    Schwartz, M. E.
    Llovet, J. M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S554 - S555
  • [43] Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection
    Song, Peipei
    Midorikawa, Yutaka
    Nakayama, Hisashi
    Higaki, Tokio
    Moriguchi, Masamichi
    Aramaki, Osamu
    Yamazaki, Shintaro
    Aoki, Masaru
    Teramoto, Kenichi
    Takayama, Tadatoshi
    CANCER MEDICINE, 2019, 8 (13): : 5862 - 5871
  • [44] Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis
    Xue, Tong-Chun
    Zhang, Bo-Heng
    Ye, Sheng-Long
    Ren, Zheng-Gang
    TUMOR BIOLOGY, 2015, 36 (08) : 5891 - 5899
  • [45] Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
    Auer, Timo Alexander
    Collettini, Federico
    Segger, Laura
    Pelzer, Uwe
    Mohr, Raphael
    Krenzien, Felix
    Gebauer, Bernhard
    Geisel, Dominik
    Hosse, Clarissa
    Schoening, Wenzel
    Fehrenbach, Uli
    CANCERS, 2023, 15 (09)
  • [46] Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
    Calderaro, Julien
    Di Tommaso, Luca
    Maille, Pascale
    Beaufrere, Aurelie
    Nguyen, Cong Trung
    Heij, Lara
    Gnemmi, Viviane
    Graham, Rondell P.
    Charlotte, Frederic
    Chartier, Suzanne
    Wendum, Dominique
    Vij, Mukul
    Allende, Daniela
    Diaz, Alba
    Fuster, Carla
    Riviere, Benjamin
    Herrero, Astrid
    Augustin, Jeremy
    Evert, Katja
    Calvisi, Diego Francesco
    Leow, Wei Qiang
    Leung, Howard Ho Wai
    Bednarsch, Jan
    Boleslawski, Emmanuel
    Rela, Mohamed
    Chan, Anthony Wing-Hung
    Forner, Alejandro
    Reig, Maria
    Pujals, Anais
    Favre, Loetitia
    Allaire, Manon
    Scatton, Olivier
    Uguen, Arnaud
    Trepo, Eric
    Sanchez, Lukas Otero
    Chatelain, Denis
    Remmelink, Myriam
    Boulagnon-Rombi, Camille
    Bazille, Celine
    Sturm, Nathalie
    Menahem, Benjamin
    Frouin, Eric
    Tougeron, David
    Tournigand, Christophe
    Kempf, Emmanuelle
    Kim, Haeryoung
    Ningarhari, Massih
    Michalak-Provost, Sophie
    Kather, Jakob Nikolas
    Gouw, Annette S. H.
    JOURNAL OF HEPATOLOGY, 2022, 77 (06) : 1586 - 1597
  • [48] Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
    Choi, Joon Hyuk
    Ro, Jae Y.
    BIOMEDICINES, 2022, 10 (08)
  • [49] Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma
    Ishii, Takamichi
    Ito, Takashi
    Sumiyoshi, Shinji
    Ogiso, Satoshi
    Fukumitsu, Ken
    Seo, Satoru
    Taura, Kojiro
    Uemoto, Shinji
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [50] Combined hepatocellular-cholangiocarcinoma - Cytologic findings in four cases
    Dusenbery, D
    ACTA CYTOLOGICA, 1997, 41 (03) : 903 - 909